Content about hypertension

March 21, 2013

University of Nebraska Medical Center implements outcome-oriented treatment model with Walgreens

In collaboration with Walgreens, the University of Nebraska Medical Center unveiled a new treatment model to help positively impact clinical outcomes for hypertension and Type 2 diabetes patients through a program made possible by a National Association of Chain Drug Stores Foundation grant.

KEARNEY, Neb. — In collaboration with Walgreens, the University of Nebraska Medical Center on Wednesday unveiled a new treatment model to help positively impact clinical outcomes for hypertension and Type 2 diabetes patients through a program made possible by a National Association of Chain Drug Stores Foundation grant.

March 15, 2013

PharmaSmart kiosks validated in two independent studies, new clinical integration announced

PharmaSmart International’s comprehensive blood pressure program has recently been validated in two new, independent scientific studies, the company announced today. The company also announced a partnership with Rx-30 Pharmacy System that offers an automated clinical integration of validated PharmaSmart biometrics within the patient record.

ROCHESTER, N.Y. — PharmaSmart International’s comprehensive blood pressure program has recently been validated in two new, independent scientific studies, the company announced today. The company also announced a partnership with Rx-30 Pharmacy System that offers an automated clinical integration of validated PharmaSmart biometrics within the patient record.

February 15, 2013

Reports: Study finds salt reduction would reduce cardiovascular-related deaths

A new study indicates that the United States could prevent up to half a million deaths during the next 10 years by reducing salt intake, according to published reports.

NEW YORK — A new study indicates that the United States could prevent up to half a million deaths during the next 10 years by reducing salt intake, according to published reports.

February 14, 2013

United Therapeutics resubmits application for pulmonary arterial hypertension drug

The Food and Drug Administration has accepted the resubmission of a regulatory approval application from United Therapeutics for a drug to treat pulmonary arterial hypertension, the drug maker said.

SILVER SPRING, Md. — The Food and Drug Administration has accepted the resubmission of a regulatory approval application from United Therapeutics for a drug to treat pulmonary arterial hypertension, the drug maker said Thursday.

The FDA originally declined to approve the drug, treprostinil diolamine extended-release tablets, in a letter submitted to the company in October 2012.

The agency plans to decide whether or not to approve the drug in March of this year, United Therapeutics said.

February 11, 2013

Bartell Drugs introduces PharmaSmart kiosks

Bartell Drugs has introduced PharmaSmart blood pressure testing kiosks at all 58 of its stores, the regional retail pharmacy chain said Monday.

SEATTLE — Bartell Drugs has introduced PharmaSmart blood-pressure testing kiosks at all 58 of its stores, the regional retail pharmacy chain said Monday.

Bartell said it was the first drug store chain in the Pacific Northwest to provide the new kiosks, made by Rochester, N.Y.-based PharmaSmart International.

February 1, 2013

Patients taking obesity drug experience improvement in cardiovascular risk factors, study finds

Patients who take a drug for losing weight may experience improvement in multiple cardiovascular disease risk factors, according to a new study.

MOUNTAIN VIEW, Calif. — Patients who take a drug for losing weight may experience improvement in multiple cardiovascular disease risk factors, according to a new study.

December 7, 2012

Mylan launches generic hypertension drug

The Food and Drug Administration has approved a generic hypertension drug made by Mylan, the company said.

PITTSBURGH — The Food and Drug Administration has approved a generic hypertension drug made by Mylan, the company said.

Mylan announced the approval and launch of candesartan cilexetil and hydrochlorothiazide tablets in the 16/12.5-mg, 32/12.5-mg and 32/25-mg strengths. Mylan said it was the first company to submit a complete regulatory approval application for the drug and is thus entitled to 180 days of market exclusivity in which to compete directly with the branded version.

November 19, 2012

Dr. Reddy's launches PAH drug

Dr. Reddy's Labs has launched a generic drug for treating pulmonary arterial hypertension, the company said.

HYDERABAD, India — Dr. Reddy's Labs has launched a generic drug for treating pulmonary arterial hypertension, the company said.

Dr. Reddy's announced the launch of sildenafil tablets in the 20 mg strength in 90-count bottles. The drug is a generic version of Pfizer's Revatio.

Revatio had sales of $338.67 million during the 12-month period ended in September, according to IMS Health.

November 13, 2012

FDA approves Mylan pulmonary arterial hypertension drug

The Food and Drug Administration has approved a generic drug made by Mylan for treating pulmonary arterial hypertension, the drug maker said Tuesday.

PITTSBURGH — The Food and Drug Administration has approved a generic drug made by Mylan for treating pulmonary arterial hypertension, the drug maker said Tuesday.

Mylan announced the FDA approval of sildenafil citrate tablets in the 20-mg strength, a generic version of Pfizer's Revatio. The drug is used to treat adults with PAH to improve exercise ability and delay clinical worsening of the condition.

Revatio had sales of about $339 million during the 12-month period ended in September, according to IMS Health.

November 12, 2012

FDA approves Watson PAH drug

The Food and Drug Administration has approved a generic drug for pulmonary arterial hypertension made by Watson Pharmaceuticals, the drug maker said Monday.

PARSIPPANY, N.J. — The Food and Drug Administration has approved a generic drug for pulmonary arterial hypertension made by Watson Pharmaceuticals, the drug maker said Monday.

Watson said the FDA approved its sildenafil tablets in the 20 mg strength through a subsidiary. Watson said it would launch the drug "in the near future."

The drug is a generic version of Pfizer's Revatio tablets, which had sales of about $339 million during the 12-month period ended in September, according to IMS Health.

November 8, 2012

Walmart to sell hypertension drugs for 1 cent

Members of a prescription-drug program offered by Humana to Medicare beneficiaries will soon be able to obtain hypertension drugs from Walmart for a penny.

BENTONVILLE, Ark. — Members of a prescription drug program offered by Humana to Medicare beneficiaries will soon be able to obtain hypertension drugs from Walmart for a penny.

That's right: $0.01.

October 23, 2012

United Therapeutics awaits FDA decision on oral PAH drug as Sandoz seeks generic approval

The Food and Drug Administration is expected to decide at the end of this week whether to approve a new oral drug for pulmonary arterial hypertension made by United Therapeutics.

NEW YORK — The Food and Drug Administration is expected to decide at the end of this week whether to approve a new oral drug for pulmonary arterial hypertension made by United Therapeutics.

October 18, 2012

PharmaSmart teams up with hypertension campaign

A company that makes health kiosks has joined a campaign to promote blood pressure management among patients with hypertension.

ROCHESTER, N.Y. — A company that makes health kiosks has joined a campaign to promote blood pressure management among patients with hypertension.

September 28, 2012

FDA approves two generic hypertension drugs from Mylan

Generic drug maker Mylan has received regulatory approval for a drug used to treat high blood pressure, also known as hypertension, the company said Friday.

PITTSBURGH — Generic drug maker Mylan has received regulatory approval for a drug used to treat high blood pressure, also known as hypertension, the company said Friday, saying that it would launch both drugs immediately.

Mylan said the Food and Drug Administration approved its irbesartan tablets in the 75 mg, 150 mg and 300 mg strengths and irbesartan and hydrochlorothiazide tablets in the 150 mg/12.5 mg and 300 mg/12.5 mg strengths. The drugs are respectively generic versions of Sanofi's Avapro and Avalide.

September 21, 2012

FDA approves Mylan hypertension drug

The Food and Drug Administration has approved a blood pressure medication made by Mylan.

PITTSBURGH — The Food and Drug Administration has approved a blood pressure medication made by Mylan.

The drug maker announced Friday the approval of valsartan and hydrochlorothiazide tablets in the 80-mg/12.5-mg, 160-mg/12.5-mg, 160-mg/25-mg, 320-mg/12.5-mg and 320-mg/25-mg strengths.

The drug, a generic version of Novartis' Diovan HCT, is used to treat high blood pressure, or hypertension, in patients who can't control their blood pressure with one drug or who are starting therapy and need multiple drugs.

September 11, 2012

Dr. Reddy's launches generic hypertension pill

Generic drug maker Dr. Reddy's Labs has launched a generic drug for treating high blood pressure, the company said.

HYDERABAD, India — Generic drug maker Dr. Reddy's Labs has launched a generic drug for treating high blood pressure, the company said.

Dr. Reddy's announced the launch of metoprolol succinate extended-release tablets in the 25-mg, 50-mg, 100-mg and 200-mg strengths. The drug will be available in bottle counts of 100 and 500.

The drug is a generic version of AstraZeneca's Toprol-XL, branded and generic versions of which had sales of about $1.13 billion during the 12-month period that ended in June, according to IMS Health.

September 10, 2012

Study finds hearing loss a significant drag on seniors' quality of life

Some of the most commonly cited health problems affecting the elderly are hypertension, stroke and osteoporosis, but a new study highlights what researchers call an even bigger problem.

MINNETONKA, Minn. — Some of the most commonly cited health problems affecting the elderly are hypertension, stroke and osteoporosis, but a new study highlights what researchers call an even bigger problem.

Americans ages 65 years and older said that hearing impairment affects their quality of life physically and mentally more than high blood pressure, stroke, osteoporosis, sciatica and cancer, according to the study, released Thursday by AARP Services and UnitedHealthcare.

September 7, 2012

Takeda: Edarbyclor statistically superior in reducing blood-pressure levels among hypertension patients

A Takeda drug designed to treat hypertension was statistically superior to another drug combination in reducing systolic blood pressure among patients in a 10-week, late-stage clinical trial.

DEERFIELD, Ill. — A Takeda drug designed to treat hypertension was statistically superior to another drug combination in reducing systolic blood pressure among patients in a 10-week, late-stage clinical trial.

September 5, 2012

NCPA signs onto 'Team Up. Pressure Down.' initiative to encourage patient-pharmacist consults

The National Community Pharmacists Association on Wednesday announced that it is participating in the "Team Up. Pressure Down." program to help hypertensive patients more effectively manage and control their high blood pressure — and ultimately prevent 1 million heart attacks and strokes by 2017.

ALEXANDRIA, Va. — The National Community Pharmacists Association on Wednesday announced that it is participating in the "Team Up. Pressure Down." program to help hypertensive patients more effectively manage and control their high blood pressure — and ultimately prevent 1 million heart attacks and strokes by 2017.

July 31, 2012

MinuteClinic, American Heart Association collaborate for hypertension management

CVS Caremark’s MinuteClinic has teamed up with the American Heart Association in a nationwide effort to improve the identification, treatment and management of high blood pressure.

WOONSOCKET, R.I. — CVS Caremark’s MinuteClinic has teamed up with the American Heart Association in a nationwide effort to improve the identification, treatment and management of high blood pressure.

According to the American Heart Association, 1-out-of-3 American adults has high blood pressure or hypertension. Uncontrolled high blood pressure can lead to stroke, heart attack, heart failure and kidney failure.

July 16, 2012

CVS Caremark research finds link between medication adherence, employee productivity

Employees with such chronic diseases as asthma, diabetes and high blood pressure spend fewer days out of the office when they are adherent to their medications, according to new research conducted by CVS Caremark and Truven Health Analytics (previously the healthcare business of Thomson Reuters).

WOONSOCKET, R.I. — Employees with such chronic diseases as asthma, diabetes and high blood pressure spend fewer days out of the office when they are adherent to their medications, according to new research conducted by CVS Caremark and Truven Health Analytics (previously the healthcare business of Thomson Reuters).

July 5, 2012

FDA gives tentative approval to generic hypertension drug

Actavis has received a preliminary approval for a generic drug for treating high blood pressure, the drug maker said Thursday.

MORRISTOWN, N.J. — Actavis has received a preliminary approval for a generic drug for treating high blood pressure, the drug maker said Thursday.

July 2, 2012

The Little Clinic partners with University of Louisville Physicians

The Little Clinic has announced a collaborative affiliation with the University of Louisville Physicians’ Preventive Cardiology practice, which marks the third affiliation that The Little Clinic has formed with a medical group.

NASHVILLE, Tenn. — The Little Clinic has announced a collaborative affiliation with the University of Louisville Physicians’ Preventive Cardiology practice, which marks the third affiliation that The Little Clinic has formed with a medical group.

The partnership focuses on the management of hypertension for patients currently without a primary care physician. The relationship will create more convenient and affordable treatment by offering much of the ongoing monitoring for hypertension at The Little Clinic locations inside select Louisville Kroger stores.

June 26, 2012

Partnering with patients to manage diabetes and other chronic diseases

The life of a patient with diabetes is a juggling act to maintain good glycemic control — from daily blood-glucose testing to eating healthy and staying active. This is a complex and sometimes inconvenient task requiring significant commitment. Today, the American Diabetes Association estimates 60 percent of diabetes patients do not adhere to their treatment regimen.

June 21, 2012

RxAlly launches blood-pressure education campaign

RxAlly has created a new campaign that is designed to support the Million Hearts initiative.

LEESBURG, Va. — RxAlly has created a new campaign that is designed to support the Million Hearts initiative.